Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



AMGEN TO HOST WEBCAST TO DISCUSS MARITIDE PHASE 2 RESULTS AND PROGRESS ON DEVELOPMENT PROGRAM

November 29, 2024
Amgen Inc., a leading biotechnology company, announced today that it will be hosting a webcast to discuss the results of the Maritide Phase 2 clinical trial and provide updates on its development program. Maritide is a promising drug candidate for the treatment of a certain type of cancer, and the Phase 2 results are highly anticipated by investors and the medical community.

During the webcast, Amgen's top executives and key researchers will present the data collected from the clinical trial, highlighting the drug's effectiveness and safety profile. They will also discuss the next steps in the development program, including plans for Phase 3 trials and potential regulatory submissions.

Investors and healthcare professionals are eagerly waiting for these results, as the success of Maritide could have a significant impact on Amgen's future revenue and growth prospects. Analysts expect that positive Phase 2 results could further boost the company's stock price, which has already shown strong performance in recent months.

However, it is important to note that investing in biotechnology stocks can be highly volatile and risky. Therefore, it is recommended to seek the advice of professionals, such as those from Stocks Prognosis, who specialize in analyzing market trends and providing accurate forecasts.

To stay informed about the latest updates and make well-informed investment decisions, considering seeking guidance from professionals like Stocks Prognosis.
If you want to leave a comment, then you need Login or Register





Other data for AMGN

Related data

AMGNJuly 30, 2025Amgen Inc. NASDAQ:AMGN Shares Unloaded by Rep. Jefferson Shreve  ~1 min.

Recently, Representative Jefferson Shreve unloaded a significant number of Amgen Inc. (NASDAQ:AMGN) shares....


AMGNApril 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025  ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....


AMGNMarch 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy  ~1 min.

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....


AMGNMarch 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market  ~2 min.

Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....


AMGNMarch 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance  ~2 min.

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....


AMGNMarch 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy  ~2 min.

Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....


AMGNMarch 10, 2025AMGEN INC. Hits Price Target Forecast with 20.7% Profit: A Success Story for QuantWave  ~1 min.

AMGEN INC. has recently reached the price target forecast set by QuantWave, resulting in a significant profit of 20.7% for investors who followed the predictive signal....


AMGNMarch 7, 2025AMGEN INC. Hits Price Target Forecast with 19.78% Profit, as Predicted by QuantWave  ~2 min.

AMGEN INC. (AMGN) recently achieved the price target forecast set by QuantWave, resulting in a profit of 19.78% for investors who followed the prediction....


AMGNFebruary 27, 2025Amgen Inc. AMGN: A Promising Investment Opportunity in the Pharmaceutical Industry  ~2 min.

Amgen Inc. (AMGN), a leading biotechnology company, is regarded as one of the best investment options in the pharmaceutical sector, according to analysts at Yahoo Finance....


AMGNFebruary 26, 2025Amgen Inc. AMGN: Among the Cheap Pharmaceutical Stocks to Buy According to Analysts  ~1 min.

Analysts have identified Amgen Inc. (NASDAQ:AMGN) as one of the cheap pharmaceutical stocks to buy....


BIIBJanuary 1, 2025Biogen Inc. (BIIB): A Healthcare Stock with Long-Term Value  ~2 min.

Biogen Inc. (BIIB) is a leading biotechnology company that specializes in developing innovative therapies for neurodegenerative diseases....


BIIBJanuary 1, 2025Biogen Inc. BIIB: Revolutionary Drug Breakthroughs Position Company for Success in 2025  ~2 min.

Biogen Inc., the leading biotechnology company, is making waves in the healthcare industry with their groundbreaking drug innovations....


JNJMarch 14, 2025Johnson & Johnson's Decades-Long Quest for Effective IBD Treatments  ~1 min.

Johnson & Johnson has been investing in research and development for decades in order to find effective treatments for inflammatory bowel disease (IBD)....


BIIBJanuary 2, 2025Biogen Inc.: Revolutionizing Healthcare with Innovative Biotechnology  ~2 min.

Biogen Inc. (BIIB) is setting new standards in the healthcare industry with its groundbreaking biotechnology solutions....


AMGNNovember 27, 2024Daiwa Securities Group Inc. Buys 12932 Shares of Amgen Inc.  ~2 min.

Amgen Inc., a leading biotechnology company, has recently welcomed a significant investment from Daiwa Securities Group Inc....